Originally presented on September 10th, 2021 as a main session at the 2021 Virtual MDF Annual Conference.
Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field. Day 1 to feature AMO Pharma, Avidity Biosciences, Harmony Biosciences & Dyne Therapeutics.
- Ibraheem Mahmood, AMO Pharma
- Elizabeth Ackermann, PhD, Avidity Biosciences
- Jeffrey M. Dayno, MD, Harmony Biosciences
- William Jacobson, PhD, Harmony Biosciences
- Ashish Dugar, PhD, Dyne Therapeutics